Felicia has had a multi-dimensional business career across the spectrum of finance, including treasury, enterprise risk management, accounting, and audit. Felicia has more than 35 years of experience leading multinational corporations such as Macy’s, Inc., The Coca-Cola Company, and Bristol Myers Squibb. Felicia is also a member of the Board of Directors of Paycom and Anywhere Real Estate.

Tony became CEO of NeoGenomics in April 2025. Prior to becoming CEO, he was a Board member for two years, serving as Chair of the Compensation committee and a member of the Audit and Technology committees. Tony has significant experience as a brand and marketing executive, with a focus on managing the interface between commercial and research and development aspects of an organization.

With 40 years of executive leadership in medical device and health care services, David serves as an independent board member and advisor to several corporations and nonprofit organizations. His expertise encompasses growing and scaling highly regulated global businesses organically through R&D and innovation and inorganically through M&A, leading within a variety of foreign, public, and private equity ownership structures; strategic planning; culture and talent development; succession planning; enterprise risk management; operations; compliance; and corporate governance.